Lightspeed Microscopy raises $4M Series A from Dynamk Capital to commercialize 3D pathology imaging platform

Lightspeed Microscopy, a Seattle startup spun out of the University of Washington, raised $4 million in a Series A led by Dynamk Capital to commercialize an end-to-end 3D pathology microscopy platform that optically clears and rapidly scans intact samples, then uses cloud-based AI to produce 3D images for pharma and clinical use.

NNicholas Reder DDynamk Capital UUniversity of Washington